Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(18%)
Results Posted
83%(5 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_4
3
27%
Ph phase_1
1
9%
Ph phase_3
3
27%
Ph phase_2
3
27%

Phase Distribution

1

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
3(30.0%)
Phase 4Post-market surveillance
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Terminated(3)

Detailed Status

Completed6
Withdrawn2
Active, not recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 23 (30.0%)
Phase 33 (30.0%)
Phase 43 (30.0%)

Trials by Status

withdrawn218%
completed655%
terminated19%
active_not_recruiting218%

Recent Activity

2 active trials
Showing 5 of 11
active_not_recruitingphase_2

Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

NCT03841058
active_not_recruitingphase_4

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

NCT04467983
completedphase_4

Abaloparatide Before Total Knee Arthroplasty

NCT04167163
terminatedphase_2

PTH Analog Type II Odontoid Fracture

NCT04760782
withdrawnphase_4

Supracondylar Distal Femur Fractures and Abaloparatide

NCT04626141
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT03841058Phase 2

Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Active Not Recruiting
NCT04467983Phase 4

Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone

Active Not Recruiting
NCT04167163Phase 4

Abaloparatide Before Total Knee Arthroplasty

Completed
NCT04760782Phase 2

PTH Analog Type II Odontoid Fracture

Terminated
NCT04626141Phase 4

Supracondylar Distal Femur Fractures and Abaloparatide

Withdrawn
NCT04974723

Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women

Completed
NCT03512262Phase 3

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

Completed
NCT04064411Phase 3

Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis

Completed
NCT03746041Phase 1

A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes

Completed
NCT03710889Phase 3

Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption

Completed
NCT03708926Phase 2

Effect of Abaloparatide on Lumbar Disc Degeneration

Withdrawn

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11